Certificate of Analysis
Reported purity: 99.89%Freedom Diagnostics · 10mg sample
Freedom Diagnostics report dated June 22, 2026. Tested sample: PT-141 10mg. Purity: 99.89%. Net content: 13.08mg. Lot: BB-20260610-C883.
Attract
PT-141
Desire, awakened.
Certificate of Analysis
Reported purity: 99.89%Freedom Diagnostics · 10mg sample
Freedom Diagnostics report dated June 22, 2026. Tested sample: PT-141 10mg. Purity: 99.89%. Net content: 13.08mg. Lot: BB-20260610-C883.
Bundle offer
Mix any 3+ products
Quantities count. Discount applies to every eligible item.
Bacteriostatic water is excluded and does not count toward the 3.
Also available as
Pre-filled penATTRACTPT-141 (Bremelanotide)Rp 1.750.00010 mgOrder Inclusions
What it does for you
- Works through the brain rather than blood flow, a fundamentally different approach
- Enhances sexual desire and response in both men and women
- Effective where conventional options fall short by targeting the mind, not the body
- Many people also report a general mood lift alongside its primary effects
PT-141 Research Notes
What is PT-141?
PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist — a cyclic heptapeptide developed from Melanotan II after researchers observed its potent effects on sexual arousal during tanning research at the University of Arizona. Unlike Melanotan II, PT-141 was developed specifically to target sexual function rather than pigmentation.
It acts primarily on the MC3 and MC4 melanocortin receptors in the central nervous system — a mechanism that distinguishes it from PDE5 inhibitors like sildenafil, which act peripherally on vascular smooth muscle. PT-141 received FDA approval for hypoactive sexual desire disorder in premenopausal women (Vyleesi, 2019), making it one of the few peptides in our catalogue with full regulatory approval for a sexual health indication.
What the research shows
Sexual desire: Phase III trials in women with hypoactive sexual desire disorder showed significant improvements in satisfying sexual events and desire scores versus placebo.
Male sexual function: Clinical studies show PT-141 produces erection in men, including those who do not respond to PDE5 inhibitors, consistent with its central rather than peripheral mechanism.
CNS mechanism: Unlike vascular-acting compounds, PT-141 works centrally on desire and arousal pathways — relevant to cases where the primary issue is desire rather than physical response.
Side effects in trials: Nausea, flushing, and injection site reactions were most common — generally transient and dose-dependent.
Ordering PT-141 in Bali
PT-141 is not a controlled substance under Indonesian BPOM regulations. Same-day delivery may be possible only after the team confirms the exact item, current availability, route, daily cutoff, complete villa or hotel address, and timing before ordering.
Common Questions
Q: How does PT-141 differ from Melanotan II?
Melanotan II also activates MC4 receptors but additionally targets MC1 strongly, producing significant tanning and more pronounced side effects. PT-141 was refined to optimise sexual function with a reduced pigmentation and side effect profile.
Q: How does it differ from Viagra or Cialis?
PDE5 inhibitors act peripherally on vascular smooth muscle to facilitate physical response. PT-141 acts centrally on desire and arousal pathways. They can be relevant to different underlying mechanisms and are sometimes researched in combination.
Q: Storage?
Refrigerate at 2–8°C. Use within 28 days of reconstitution. Ships cold-packed.